These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 650199)

  • 21. MAOI-induced hypersomnia in patients with bulimia.
    Gray GE
    Am J Psychiatry; 1989 Aug; 146(8):1078. PubMed ID: 2750986
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenelzine vs placebo in 50 patients with bulimia.
    Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
    Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenelzine as a stimulant drug antagonist: a preliminary report.
    Maletzky BM
    Int J Addict; 1977 Aug; 12(5):651-5. PubMed ID: 924698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study.
    Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
    Arch Gen Psychiatry; 1984 Nov; 41(11):1105-9. PubMed ID: 6388524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
    Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D
    Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069
    [No Abstract]   [Full Text] [Related]  

  • 26. Quadriplegia, orthostatic hypotension, and phenelzine with tyramine.
    Wood CA; Riddle J; Reed R; Paul C
    Ann Intern Med; 1985 Nov; 103(5):803-4. PubMed ID: 4051358
    [No Abstract]   [Full Text] [Related]  

  • 27. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
    Mountjoy CQ; Roth M; Garside RF; Leitch IM
    Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B; Osse RJ; Emmer B; van Kooten F
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
    [No Abstract]   [Full Text] [Related]  

  • 31. [The immediate and late results of treating neurodermatitis by the indirect endolymphatic administration of drug preparations].
    Shakhtmeĭster IIa; Pisarenko MF
    Vestn Dermatol Venerol; 1988; (11):12-3. PubMed ID: 3239222
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual reaction to monoamine oxidase inhibitor.
    Gardner LD
    Br Med J; 1979 May; 1(6172):1218-9. PubMed ID: 445031
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
    Rabkin JG; Quitkin FM; McGrath P; Harrison W; Tricamo E
    J Clin Psychopharmacol; 1985 Feb; 5(1):2-9. PubMed ID: 3973068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
    Martin WE; Loewenson RB; Resch JA; Baker AB
    Neurology; 1974 Oct; 24(10):912-9. PubMed ID: 4606107
    [No Abstract]   [Full Text] [Related]  

  • 36. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness of the new Soviet preparation bicarfen in neurodermatitis patients].
    Ushakov IV
    Vestn Dermatol Venerol; 1984 Mar; (3):37-40. PubMed ID: 6145267
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of refractory cases of depressive illnesses and their response to combined antidepressant treatment.
    Sethna ER
    Br J Psychiatry; 1974 Mar; 124(0):265-72. PubMed ID: 4599813
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoamine oxidase inhibitor-induced speech blockage.
    Goldstein DM; Goldberg RL
    J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
    Fenwick MJ; Muwanga CL
    J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.